HOVERINK BIOTECHNOLOGIES APPOINTS VSTOCK TRANSFER, LLC AS ITS TRANSFER AGENT AND REGISTRAR

World News: . []

LOS ANGELES CA July 11 2018 GLOBE NEWSWIRE -- HOVERINK BIOTECHNOLOGIES Appoints as its Hoverink Biotechnologies is currently developing IV and oral formulations of LADAVRUreg to treat chronic pain nausea and discomfort associated with che mothera...

More news and information about Hoverink Biotechnologies, Inc

Published By:

Globe Newswire: 15:24 GMT Wednesday 11th July 2018

Published: .

Search for other references to "hoverink" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us